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CHAPTER I
Introduction
Cells of the mononuclear phagocyte system include blood monocytes and
tissue macrophages. These cells function in the development of both humoral
and cell mediated immunity and also serve as one of the major phagocytic
cell systems of the body.
Glucocorticoids and their effect on cells of the mononuclear phago-
cyte system have been studied in species other than the canine. Gluco-
corticoids are used in canine medicine for the treatment of a number of
disorders including allergic disorders, immune-mediated diseases, neo-
plasms and shock.
The objectives of this project were to evaluate and partially charac-
terize blood monocytes, alveolar macrophages and peritoneal macrophages:
1) in normal dogs, 2) in the same dogs following a shock dose of gluco-
corticoids and 3) in the same dogs following immunosuppressive doses of
glucocorticoids
.
CHAPTER II
Literature Review
The mononuclear phagocyte system, composed of blood monocytes and
tissue macrophages, is one of the major immune defense systems of the body.
Macrophages have phagocytic capability (immune- and nonimmune-mediated)
and are intimately involved with induction of the immune response (humoral
and cell mediated). 1 » 2 »3
Genesis, Morphology and Function
All the formed elements of the blood are derived from a common pluri-
potential stem cell in the bone marrow, which gives rise to myeloid and
lymphoid stem cells. 1* The myeloid stem cells differentiate further into
erythroid precursors, megakaryocyte precursors and colony-forming units-
granulocyte, monocyte (CFU-G, M) . The CFU-G, M gives rise to the granu-
locytic and monocytic series. Granulocyte and monocyte colonies require
a hormone, referred to as colony-stimulating factor (CSF), to grow in cul-
ture media. " The primary sources of human CSF are blood monocytes,
tissue macrophages and activated T lymphocytes.^ Stimulation of T lympho-
cytes by lectins or antigens and stimulation of circulating monocytes and
tissue macrophages with a number of materials such as endotoxin may result
in release by these cells of an increased amount of CSF, which may cause
an increased proliferation of monocyte precursors. 1* Monocytes and macro-
phages produce prostaglandins of the E series that have a direct inhibitory
effect on hematopoietic colony-forming cells committed to macrophage differ-
entiation. 5 Low concentrations of prostaglandin E2 (PGE2) selectively
suppress macrophage colony formation without altering granulocyte colony
formation. If macrophages are exposed to high levels of CSF, they increase
their PGE2 synthesis which then may act as a negative feedback mechanism
to limit excessive monocyte production. Granulocytes produce lactoferrin,
which supresses CSF production by mononuclear phagocytes. 5 Thus, mono-
cyte production is regulated by a number of factors, including CSF which
stimulates production, and by PGE2 which directly inhibits production,
and by lactoferrin which indirectly inhibits production by suppressing CSF
production. 1* » 5 There probably are additional as yet unidentified factors
which also play a role in regulation of monocyte and neutrophil production.
Morphologic and functional characteristics of monocytes and macro-
phages can be identified in vitro by nonspecific esterase stains, phago-
cytosis of heat-killed Candida albicans and the formation of rosettes with
sensitized sheep red blood cells. 6, 7, 8 Over fifty products have been
identified as being secreted from macrophages, including components
of the clotting system and of the complement system; lysozyme, plasminogen
activator, elastases, collagenases, interleukin-1 (IL-1), interferons, fib-
ronectin and prostaglandin E2«^'3»9 Depending upon the state of macro-
phage activation and the products they release, macrophages can function in
a variety of different capacities in the inflammatory response and in regu-
lation of cellular function. 1 Substances that are chemotactic for macro-
phages include C5a (anaphylatoxin) , bacterial products, products from
stimulated B and T lymphocytes, fragments of collagen and elastic, and de-
natured proteins. 1 Activated T cells produce macrophage chemotactic
factor (MCF), specific macrophage-arming factor (SMAF) and macrophage
stimulating factor (MSF). 10 Lymphokines (macrophage migration inhibition
factor, macrophage aggregating factor) and proteolytic enzymes produced by
activation of the complement and fibrinolytic systems inhibit the random
migration of macrophages, thereby increasing their number in sites of in-
flammation. 1 > 1
Particle ingestion (phagocytosis) by macrophages is accompanied by
an increased consumption of oxygen and a series of biochemical events that
produce highly reactive oxygen metabolites. This increase in oxygen con-
sumption with the resultant generation of oxygen metabolites is referred to
as the respiratory burst. The reactive oxygen metabolites include hydrogen
peroxide, superoxide anion, singlet oxygen, hydroxyl radicals, chloramines
and aldehydes. These metabolites are toxic to microorganisms and are impor-
tant in macrophage killing of intracellular pathogens
.
1
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Cells of the mononuclear phagocyte system have receptors for IgG and the
third component of complement (C3b) in their plasma membrane. 12 »13 Mono-
nuclear phagocytes that are capable of antigen-processing for presentation
to lymphocytes have la antigen present in their plasma membrane. The la
antigen is a major histocompatibility antigen.
3
The receptors for IgG are specific for the Fc portion of the IgG mole-
cule. 1 3 Fc-receptors and complement component (C3) receptors function in
the antibody and complement binding capacity of macrophages, in antigen
presentation to lymphocytes (B and T) and in immune mediated phagocyto-
sis. 1 2., 13 Fc-receptors are capable of binding IgG and initiating phago-
cytosis while complement (C3) receptors bind particles but do not initiate
phagocytosis. 1 » 1i* Inactive C3-receptors can become activated by specific
lymphokines to respond to molecules on the substrate to which macrophages
are attached in vitro . 1i* The in vivo activation of macrophage C3-
receptors requires the presence of immune complexes and T lymphocytes. 11*
When particles are phagocytosed via Fc-receptor mechanisms, the macro-
phages release large amounts of reactive oxygen metabolites (superoxide
anion, free hydroxyl group and hydrogen peroxide) and arachidonic acid
metabolites (prostaglandins and leukotrienes) . In contrast to Fc-receptor
mediated phagocytosis, neither active or inactive C3-receptor activity re-
sult in the release of hydrogen peroxide or arachidonic acid metabolites. 1 **
This observed difference in the secretion of inflammatory mediators during
the phagocytic process suggests that activated C3-receptor-mediated phago-
cytosis may be a mechanism to clear opsonized particles without initiating
an increased inflammatory response. 11*
Macrophages are heterogeneous in their affinity for IgG. 12 Guinea
pig peritoneal macrophages have an affinity for IgG that is 3 1/2 times
greater than that of alveolar macrophages. 12 Peritoneal exudate macro-
phages that are elicited by injecting an irritant into the peritoneal cav-
ity have a six fold increase in the proportion of cells with a high affin-
ity for IgG. 12 Alveolar macrophages have a broader range of cellular
affinity for IgG than do peritoneal macrophages, which may be related to
the aerobic environmental conditions for the alveolar macrophages. 12
A greater proportion of canine alveolar macrophages have Fc-receptors than
do canine blood monocytes, and canine alveolar macrophages also have greater
phagocytic ability than do canine blood monocytes. 1 5
Macrophage populations differ in their expression of the la antigen
depending upon the compartment in which the macrophages reside. 1 6 The
percent of cells (monocytes, macrophages) expressing the la antigen in bone
marrow is 20-80$, peritoneal exudate 30-50$, thymic macrophages 40-60$,
alveolar macrophages 5-80$ and splenic macrophages 40-60$. 1 6 The local
concentration of prostaglandin in each tissue controls the amount of la-
positive macrophages within that tissue due to prostaglandin E2 inhib-
iting the induction of la-positive macrophages. 1 ? when la-negative
macrophages are compared to la-positive macrophages, the former have
an increased number of Fc- and C3-receptors, equal bacterial binding and
latex phagocytosis, and equal IL-1 secretion following endotoxin activation.
Ia-negative macrophages do not secrete IL-1 following T cell-macrophage
interaction while la-positive macrophages do. 1 ?
Traffic of Mononuclear Phagocytes
Monocytes leave the bone marrow within 24 hours of completing their
last division, thus, unlike the bone marrow granulocytes, there is no
marrow reserve pool of monocytes.'* There is no substantial marginated
pool of monocytes; thus, the blood monocyte pool is composed almost en-
tirely of circulating elements. Monocytes leave the circulation at random
and the half-time of disappearance of labeled monocytes from the circula-
tion appears to be about 71 hours in humans. 1 *'* Once having emigrated
from capillaries, tissue macrophages are believed to be incapable of re-
entering the circulation.
Tissue macrophages are present in a number of organs and tissues and
are referred to as alveolar macrophages in the lungs, Kupffer cells in the
liver, Langerhans cells in the skin, epithelioid cells and giant cells in
granulomatous reactions, as synovial macrophages in joint cavities, and as
peritoneal and pleural macrophages in those spaces, and as osteoclasts in
the bone. 1*
Maturational Characteristics of Cells of the Mononuclear Phagocyte System
The promonocyte is the earliest morphologically identifiable mononuclear
phagocyte progenitor in the bone marrow. * It has poorly developed phago-
cytic capacity, secretes small quantities of lysozyme and displays few Fc-
receptors. 1 »" Promonocytes, precursors of circulating monocytes, are
myeloperoxidase positive and esterase positive. 1*
Monocytes, as compared to promonocytes, have decreased myeloperoxidase
staining and an increase in lysosomes, Fc-receptors, lysozyme secretion and
phagocytic ability. Monocytes usually remain viable when they leave the
circulation and mature into tissue macrophages characteristic of the com-
partment into which they enter.
'
Mature tissue macrophages, such as pulmonary alveolar macrophages, do
not stain for myeloperoxidase. Compared to their less differentiated pre-
cusors (promonocytes, monocytes), they have increased lysosomes, phagocytic
ability, numbers of Fc-receptors and of complement receptors, and have in-
creased lymphocyte interactions.' Monocytes and tissue macrophages are
nonspecific esterase positive as are all the cells of the mononuclear
phagocyte system. The intensity of esterase staining is somewhat variable,
with alveolar macrophages staining with the most intensity followed by
blood monocytes and then by peritoneal macrophages. This property is used
as a marker for identifying cells of the mononuclear phagocyte system. 8,18
Macrophages are morphologically and functionally different between
sites (i.e. alveolar versus peritoneal) and within an organ or tissue. 1 9, 20
Peritoneal and alveolar macrophages differ in their cellular metabolism in
that alveolar macrophages utilize aerobic metabolism and peritoneal macro-
phages utilize anaerobic metabolism. 1 9 The population of resident and
paraffin-induced, stimulated guinea pig peritoneal macrophages includes 5
to 15$ with low esterase activity. 20 Human peritoneal macrophages were
predominantly perioxidase positive in one study. 21 A population of macro-
phages may respond differently to the same stimulus with respect to an array
of functions. A stimulus such as bacteria may induce a subpopulation of
peritoneal macrophages to increase phagocytic ability without altering its
Fc-receptor activity, and a second subpopulation in the same subject may
exhibit the opposite results. This has been referred to as dissociation of
function. 22 The heterogeneity of macrophages may be the result of local
environmental influences, separate subpopulations of macrophages or the
state of activation that the macrophage is in. 1 9
Pulmonary Alveolar Macrophages
Pulmonary alveolar macrophages are the primary (first-line) defense
mechanism of the gas-exchange region of the lung. 1* Resident alveolar
macrophages are derived from blood monocytes which, in turn, originated in
bone marrow. 4 Under normal steady state conditions, approximately 15% of
the monocytes leaving the circulation enter the lungs to become pulmonary
macrophages. -3 Alveolar macrophages have a very limited proliferative
capability. * The life span of human alveolar macrophages is unknown. 4
The pulmonary alveolar macrophage population in mice is reported to have a
turnover time of one month. 24 Activation of resident macrophages and
recruitment of circulating monocytes into alveoli are part of the response
of the lung to an irritant. The influx of macrophages derived from the
peripheral blood provides the main source of macrophages for pulmonary
defense, while resident macrophages act briefly as sentinels to call in
neutrophils and blood monocytes. When resident alveolar macrophages are
stimulated by specific or nonspecific immune stimulants, the number and
affinity of Fc-receptors and C3-receptors increases. 1* Hamster alveolar
macrophages exhibited increased immune phagocytosis (Fc- and C3b-receptor-
mediated), as well as increased nonimmune yeast phagocytosis, when incubated
in supernatant fluid from Concanavalin A (Con A) -stimulated lymphocytes.
This leads to the conclusion that lymphokines are capable of enhancing both
immune and nonimmune phagocytosis by alveolar macrophages
.
25 in addition
to this, alveolar macrophages exposed to specific or nonspecific immune
stimulants have increased numbers of mitochondria and lysosomes (the latter
having increased enzyme activities) and increased metabolic activities.^
Resident alveolar macrophages produce chemotactic factors that attract
inflammatory cells (neutrophils and monocytes) to the lung and also produce
CSF which increases the production of polymorpho nuclear and mononuclear
phagocytes in the bone marrow.
Peritoneal Macrophages
Peritoneal macrophages are derived from blood monocytes. 26 The turn-
over time in mice has been reported to be approximately 19 days. 2 ^ Once in
the peritoneal cavity, macrophages retain the ability to synthesize DNA for
less than 24 hours. In mice during steady state conditions, 7.5% of the
monocytes leaving the circulation enter the peritoneal cavity. 2 ? The fate
of peritoneal macrophages is unknown, however, they may be removed from the
peritoneal cavity via lymphatic drainage and die in local lymph nodes. 2 3
Afferent Limb of Immune System
Macrophages are important in the induction of both antibody and cell-
mediated immune responses. 1 f2 Macrophages that have the la antigen upon
their surface membrane present antigens to T and B lymphocytes that respond
with their characteristic antibody or cell mediated immune response. 2
Macrophages appear to have two functions in antibody formation: 1) proces-
sing and presentation of antigens and 2) viability promotion in spleen
cells. 2 Macrophages with la antigen on their surface membranes are cap-
able of responding to antigens by phagocytosis of the antigens followed by
incorporation of the antigen on their surface membrane. Once the antigen
is associated with the macrophage membrane, it can bind to receptor sites
on T or B lymphocytes and elicit responses such as B cell differentiation
into plasma cells and IL-2 production from T lymphocytes. Macrophages are
required for the primary humoral immune response (antibody formation) to
T-cell dependent antigens. The secondary humoral immune response is much
less dependent upon macrophages and only a small number are required for
antibody formation. 2
The viability-promoting function of macrophages for spleen cells is
illustrated by the removal of macrophages from spleen cell suspensions,
which results in the inability of splenic lymphocytes to form antibody
against sheep RBC's (sRBC) . When macrophages were added to whole spleen
cell suspensions, the antibody forming ability is restored. 2
Macrophages have an active role in cell-mediated immunity. 2 The
primary sensitization of T cells in_ vitro requires antigen presentation by
macrophages. Stimulated monocytes and macrophages release interleukin-1
which previously has been referred to as lymphocyte-activating factor
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(LAF).9 Interleukin-1 is a major regulator of T lymphocyte prolifer-
ation. 9 Activated T cells produce Interleukin-2 (11-2), which also
plays a role in T lymphocyte proliferation. 28 Macrophages are re-
quired for in vitro culture of T cells and Interleukin-2 production.
Cytotoxic T cells are involved in allograft rejection and tumor immunity
and require the presence of macrophages in their induction phase. 2
Effector Limb of Immune System
Macrophages act as effector cells of the immune system and as such they
can ingest and digest microorganisms, kill tumor cells and participate in
other immunopathologic processes. 2 Macrophages are the predominant cell
type present in chronic inflammatory reactions. Macrophage migration inhi-
bition factor (MIF) is a soluble mediator released from antigen-stimulated
lymphocytes, which inhibits the random movement of macrophages in vitro
.
Macrophage chemotactic factor is another lymphokine that may be partially
responsible for the accumulation of macrophages in reactive sites in CMI
responses. 2
In canine lungs, the alveolar macrophages suppress lymphocyte prolif-
eration. 2" This suppression may be due to the production of prosta-
glandins which have been shown to suppress lymphocyte proliferation. Studies
have also shown that canine bronchoalveolar lymphocytes have an inherent
hyporesponsiveness to mitogenic stimulation. 2 ^
Glucocorticoids and the Mononuclear-Phagocyte System
Glucocorticoids are used in small animal medicine in the treatment of
a number of inflammatory, allergic, immune mediated and neoplastic diseases
11
as well as in the treatment of shock. 30 The primary allergic disorders
in small animal medicine treated with glucocorticoids are dermatological
disorders (i.e. atopy, flea allergy dermatitis). Glucocorticoids play a
very significant role in treatment of immune mediated diseases such as
autoimmune hemolytic anemia, immune mediated thrombocytopenia and systemic
lupus erythematosus. Neoplasms of the lymphoid system (i.e. lymphosarcoma,
multiple myeloma) are among the neoplasms that are glucocorticoid respon-
sive. The role of glucocorticoids in the treatment of shock remains a
controversial issue. However, a beneficial effect of glucocorticoids has
been demonstrated in treatment of endotoxic and septic shock.
Glucocorticoids are effective in inhibiting humoral and cellular
immunity, but have a greater effect on cellular immunity than on humoral
immunity. 31 >32 The glucocorticoid effect on immunoglobulin synthesis
and complement metabolism is not felt to be clinically important. 32 The
precise mechanisms involved in glucocorticoid suppression of the immune
system are not completely understood but some hypotheses have been advanced.
The mechanism of action of glucocorticoids at the cellular level may be
initiated by the interaction of glucocorticoids with specific steroid-binding
protein receptors. 32 The steroid-receptor complex may then interact with
nuclear DNA to signal the production of mRNA, which directs the production
of new proteins. These new proteins, many of which are enzymes, determine
the cellular response to the glucocorticoids. 32 in animal models it has
been shown that the loss of steroid receptors results in loss of the re-
sponse to steroid.
Glucocorticoids also affect the total and differential leukocyte counts
in canine peripheral blood. 33 The response to endogenous or exogenous
glucocorticoids by canine blood leukocytes is an increase in absolute numbers
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(leukocytosis) primarily due to a mature neutrophilia. There also is an
accompanying lymphopenia, eosinopenia, and monocytosis. 33
Monocytes and macrophages in mouse, rabbit and man have glucocorticoid
receptors.
3
1
* Mononuclear phagocytes at all stages of maturation are sen-
sitive to glucocorticoids. 35 in a study performed to evaluate the bio-
chemical actions of glucocorticoids on macrophages in culture, it was shown
that lysozyme secretion was not affected by glucocorticoids. 35 However,
the secretion of elastase, collagenase, and plasminogen activator was
inhibited by the addition of glucocorticoids to macrophage cultures. 35
Glucocorticoids exert an anti-inflammatory effect by blocking the production
of plasminogen activator. 32 Dexamethasone has been shown to inhibit
the rate of formation of macrophage colonies from mouse bone marrow stem
cells and to alter differentiation of monocytes to macrophages in
persons. 35 ,36 interaction of glucocorticoids and specific monocyte cyto-
plasmic receptors was suggested as the mechanism by which monocyte differ-
entiation is altered. 36 a six hour pulse exposure of glucocorticoids
was shown to have no effect on monocyte to macrophage differentiation in
man, however, a sustained plasma concentration did affect differentiation. 36
Glucocorticoids decrease the number of lysosomes within macrophages and
inhibit the development of macrophage tumoricidal activity and prevent/
inhibit increased lysosomal enzyme content. 36
One of the most important effects of glucocorticoid administration is
a decrease in the number of neutrophils and monocyte-macrophages at sites
of inflammation. 32 This effect on the accumulation of phagocytic cells
at inflammatory sites is probably the major mechanism of the anti-
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inflammatory effect of glucocorticoids. It is also the probable cause for
decreased immune function in patients on daily glucocorticoid therapy. 32
In vitro studies have suggested that glucocorticoids reduce the number
of macrophages in sites of inflammation by suppressing lymphokine-mediated
processes. 37 Glucocorticoids inhibit MMF (Macrophage Mitogenic Factor) and
MIF (Macrophage Migration Inhibition Factor) generation at physiological
concentrations. 37 Pharmocological concentrations of glucocorticoids were
necessary to inhibit MMF-induced macrophage proliferation. 37 other studies
have reported that glucocorticoids do not affect MIF production al-
though they do inhibit the macrophages response to MIF.3 2 Glucocorticoids
do not suppress lymphocyte production of lymphokines, but they do inhibit the
ability of the mediator to recruit cells necessary for the expression of the
response. 32
Treating mice with glucocorticoids prior to macrophage activation de-
creased Interleukin-1 production by macrophages . 38 Glucocorticoid inhibi-
tion of Interleukin-1 release from stimulated macrophages may result in
decreased lymphokine production. 37
Glucocorticoids exert their maximum activity on the immune response if
they are present prior to antigenic challenge. 31 Glucocorticoids have as
one of their primary actions the lysis of lymphocytes. 31 The transient
lymphopenia observed following glucocorticoid administration is, however, not
due to lympholysis but rather due to lymphocyte redistribution.31
Hydrocortisone suppresses interferon-induced macrophage cytotoxicity
in vitro . 39 Prostaglandin production in vitro by phagocytic cells of
the thymus is inhibited by the presence of dexamethasone. 2* The blocking
14
of Fc-receptors by glucocorticoids has been observed in guinea pig macro-
phages and it may be an important mechanism of action of glucocorticoids. 32
In vitro glucocorticoids inhibit blood monocyte Fc-receptor activity. 1* 1 The
blocking of macrophage membrane receptors (Fc-receptor, C3-receptor) by glu-
cortocoids may play a role in the observed decrease in macrophage clearance of
antibody-coated and antibody-complement-coated erythocytes in steroid-treated
animals. 32 Glucocorticoid administration has been associated with a dose-
dependent decrease in monocyte Fc-receptor numbers in normal persons and in
patients with auto-immune hemolytic anemia. 2 ^in vitro incubation of mouse
peritoneal macrophages with glucocorticoids yielded no change in the basal
values for Fc-mediated phagocytosis. Incubation with glucocorticoids plus
interferon (gamma) resulted in increased Fc-mediated phagocytosis and binding
to a much greater extent than interferon (gamma) alone. ^3 Glucocorticoids
inhibited resting levels of la antigen and induction of la antigen by
interferon. ^3 Topical and systemic glucocorticoids in mice result in a
dose-dependent reduction in the number of la-bearing epidermal Langer-
hans cells and when incubated with mouse peritoneal macrophages, gluco-
corticoids inhibited their la antigen expression and Interleukin-1 pro-
duction.^ >^5 Glucocorticoids may result in an interference with the
antigen-presenting cell function of macrophages and T cell stimulation,
and this may be one of the mechanism that result in glucocorticoid suppres-
sion of the T cell-dependent immune response.^ 1** 1*5
Hydrocortisone inhibits prostaglandin synthesis by rat peritoneal
macrophages that are phagocytosing killed bacteria and interferes with
15
peritoneal macrophage activation. 46,17 Hydrocortisone resulted in normal
macrophages becoming unresponsive to lymphokine and it also prevented
macrophages from responding to T_. gondii ingestion with an enhanced oxi-
dative respiratory burst. Hydrocortisone readily interferes with macrophage
activation by lymphokines but only if present before or during stimula-
tion. ^7 The ability of the macrophages to inhibit intracellular toxo-
plasma replication was also decreased. **?
The effect of glucocorticoids on alveolar macrophages in species
other than dogs has been studied. It has been demonstrated that
glucocorticoid administration in guinea pigs results in a dose-dependent
reduction in pulmonary defenses to intracellular pathogens and that sup-
pression of both acquired local immunity as well as nonimmune defense
mechanisms occur.^ Additional studies utilizing guinea pigs showed
that cortisone acetate treatment appeared to adversely influence certain
chemotactic activities of pulmonary alveolar macrophages. ^9 A brief and
severe monocytopenia with no change in the number of pulmonary macrophages
followed a 3ingle dose of dexamethasone.50 in the same study, hydro-
cortisone acetate caused a severe monocytopenia for more than 144 hours
and a decrease of pulmonary macrophage population to two-thirds of normal
within 48 hours.
A study with mice showed that the number of alveolar macrophages re-
mained within normal limits during intensive glucocorticoid therapy despite
the presence of peripheral leukopenia. 51 From that study, the authors
suggest that a mechanism in the lung was able to maintain the resident
alveolar population and this was possible due to proliferation of resident
alveolar macrophages.
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Glucocorticoids may alter cell mediated immune function by affecting
the mononuclear phagocyte system. It has been suggested by several inves-
tigators that the most important effect is the decreased number of macro-
macrophages will result in a decreased number available for interaction
with other cells of the immune system. There will also be a decreased
number available to perform functions such as phagocytosis of foreign
particles and debris from damaged tissues, resisting intracellular pro-
liferation of infectious organisms, and exhibiting cytotoxic reactions
towards foreign materials. Thus, the effect of glucocorticoids on cellular
immunity is of more importance in altered resistance than its effect on
humoral immunity. However, when the population of macrophages that are able
to process and present antigen are adversely affected, the humoral system
will also be affected, especially in the formation of antibody to a T cell-
dependent antigen presented to the immune system for the first time.
17
CHAPTER III
Materials and Methods
_A. Animals
Seven male and five female adult mixed breed dogs weighing between
13.2 and 33.6 kgs were obtained from and housed by the Kansas State Univers-
ity Animal Resource Facility (ARF). These dogs were vaccinated against
canine distemper, leptospira, hepatitis, parainfluenza and canine parvo
virus with a modified live vaccine and against rabies. All dogs were
heartworm negative as determined by a modified Knott test. Fecal flotations
were performed and three dogs had Trichuris vulpis and two had Ancylostoma
canimum/Uncinaria stenocephala . All dogs were medicated with pyrantel
pamoate. 3
B. Isolation of Blood Monocytes
Blood monocytes were harvested from thirty mis of heparinized blood
collected from each dog. The blood was diluted 1:1 (10-12 ml of each) with
sterile phosphate buffered saline solution (PBSS). Eight ml of Ficoll-
sodium diatrizoate solution 13 was added to 50 ml siliconized glass centri-
fuge tubes and 10 ml of diluted blood was layered on top. Differential
migration due to differences in cell densities occurs with centrifugation.52
Following centrifugation (1500 g, 20°C, 20 min), monocytes, lymphocytes and
thrombocytes are located at the interface between the plasma and the
Ficoll-Paque. n The erythrocytes and granulocytes are found in a layer
at the bottom of the tube. The monocytes were harvested with the use of
aNemex: Pfizer Inc., New York, NY 10017
bFicoll-Paque, Pharmacia Fine Chemicals, Piscataway, NJ
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sterile pasteur pipettes from the plasma-Ficoll-Paque R interface and were
transferred to a 50 ml siliconized glass centrifuge tube. The cells were
washed with PBSS, centrifuged (1000 g, 5°C, 10 min. ) and the resultant
pellet of cells was resuspended in 2 mis of PBSS. The red blood cells
(RBCs) were lysed by the addition of ten mis of cold distilled water (for
30 seconds) followed by 10 ml of 1.7$ NaCl.
Following RBC lysis, the sample was centrifuged and the pellet was
resuspended in 10 ml RPMI 1640C medium with 10$ Bovine Fetal Serumd .
A 1:10 dilution of cells was made using 0.1 ml of the cell suspension,
0.8 ml RPMI 1640 with 10% Bovine Fetal Serum (BFS) , and 0.1 ml of 0.4$ Trypan
Blue. A total cell and viable cell count was performed. Viability was
assessed using Trypan Blue exclusion. The cells were resuspended to 4 x
106 cells/ml using RPMI 1640 with 10$ BFS.
£. Isolation of Peritoneal Macrophages
The dogs were anesthetized and maintained under anesthesia with sodium
thiamylale administered via a cephalic vein catheter. Ventral midline
celiotomies were performed using sterile surgical techniques. Five hundred
mis of sterile PBSS was instilled into the peritoneal cavity. The lavage
fluid was recovered using a 60 ml syringe attached to tubing placed into
the peritoneal cavity with a fenestrated syringe case surrounding it.
The abdomen was closed in two layers using a simple interrupted suture
CRPMI 1640: Grand Island Biological Co., Grand Island, NY 14076
dBovine Fetal Serum: KC Biological, Inc. , Lenexa, KS 66215
^io-tal: Bio-Ceutic Division, St. Joseph, MO 64502
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pattern in the linea alba and simple interrupted or continuous pattern in
the skin. The lavage fluid was filtered through 4" x 4" gauze sponges
and transferred to 50 ml siloonized glass centrifuge tubes. Following
centrifugation (1000 g, 4oc, 10 min. ) the pellet was resuspended in 2 mis
of PBSS. The RBCs were lysed as with the isolation of blood monocytes.
The remaining steps were identical to those followed for the blood monocytes
except the cells were resuspended to 4 x 10^ cells/ml.
J). Isolation of Bronchoalveolar Macrophages
Following collection of the peritoneal macrophages, the dogs were
placed in left lateral recumbency for bronchoalveolar lavage. A polyethel-
ene tube (PE-320) was passed through the endotracheal tube into the trachea
and advanced until resistance was met and then slightly withdrawn. The
lavage was performed by instilling 20 ml increments of PBSS (maximum volume
10 ml/kg) and immediately aspirating to recover the lavage fluid. The
lavaging procedure was repeated until the total volume of PBSS had been
used or a sufficient volume of fluid (100 ml) had been recovered. The
lavage fluid was filtered through 4" x 4" gauze sponges and transferred to
50 ml siliconized glass centrifuge tubes. The isolation procedure was
identical to that followed for the isolation of the peritoneal macrophages.
The cells were resuspended to 4 x 10^ cells/ml.
E. Formation of Monocyte and Macrophage Monolayers
One ml of the cell suspensions (blood monocytes, bronchoalveolar macro-
phages or peritoneal macrophages) were added to each of four wells on
two previously prepared tissue culture plates. f Plastic tissue culture
fCostar Tissue Culture Plates: Costar, Cambridge, MA
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coverslipsS had been placed in each of the wells prior to the cells being
added. The plates were incubated (37°C, w/5* C02 ) for one hour to allow
for adherence of the cells to the coverslips. Following the incubation
period, the cells in each well were washed three times using RPMI 1640 with
10* BFS to remove nonadherent cells. Plates were viewed under the inverted
microscope to check for monolayer formation. After the cells had been
washed, they were ready for either the EA-rosetting or yeast phagocytosis
assay. Cytospin preparations'1 of each of the cell suspensions were made
for nonspecific esterase staining (outlined in the following section) and
Diff Quik1 staining for differential counts.
F_. Fc-Receptor Rosette Assay
One ml of 1 J sensitized sRBCsJ was added to wells with blood mono-
cytes, bronchoalveolar macrophages and peritoneal macrophages. RPMI 1640
with *\Q% BFS was added to control wells. The plates were incubated for 20
minutes (37°C, w/5$ C02 ) and then washed with fresh RPMI 1640 with 10%
BFS. Fresh RPMI 1640 with 10$ BFS was added to each well and they were
viewed under the inverted microscope. The monolayers were stained with
Diff-Quik R
,
air dried and the coverships were mounted onto glass slides.
A total of 200 cells per preparation were counted and any cell with three or
more sRBCs attached to the cell membrane was considered a rosetting cell.
SThermanox Coverslips: Miles Scientific, Naperville, IL 60566
nCytospin 2, Shandon Southern Instruments Inc., Sewickley, PA
iHarleco Diff-Quik: American Scientific Products, N. Kansas City, M0 64116
•JRabbit anti-sheep erythrocyte immunoglobulin G, Cordis Laboratories Inc.,
Miami, FL
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G. Phagocytosis of Yeast
One ml of heat killed, new methylene blue stained Candida albicans
suspension (RPMI 1640 with 10* BFS with 2 X 10? yeast cells per ml) was
added to each well. Control wells contained macrophages and RPMI 1640
with 10* BFS. The plates were incubated (37°C, w/5% C02 ) for forty-five
minutes, and were then washed two times. Fresh RPMI 1640 with 10$ BFS was
added and the wells were viewed under the inverted microscope. The cells
were stained, air dried and the coverslips were mounted onto glass slides.
A total of 200 cells per preparation were counted and cells with three or
more ingested yeast were considered positive for phagocytosis.
JH. Non-specific Esterase Stain
Cytospin preparations of blood monocytes, peritoneal macrophages and
bronchoalveolar macrophages were prepared for staining alpha naphthyl acetate
esterase activity as has been previously described. 8 Two hundred cells
per preparation were counted. The cells that were esterase positive had
a dark red to reddish brown cytoplasm. The stain faded quickly therefore
the cell counts were performed within a few days of the staining procedure.
_I. Data Collection
The project was designed to obtain data from dogs prior to treatment
and following two different treatments of glucocorticoids. Samples were
collected from the 12 dogs prior to treatment for isolation of blood
monocytes, peritoneal macrophages and bronchoalveolar macrophages. The
resultant monolayer preparations were used for the previously outlined pro-
cedures. In addition, blood was collected for a complete blood count (CBC)
22
and serum chemistry profile (SMA-12). The data obtained from this collection
is referred to as Phase I data.
The second set of samples were collected six and 12 hours following
the intravenous administration of prednisolone sodium succinate14
(20 rag/kg) and dexamethasone sodium phosphate1 (6 mg/kg). These drugs are
referred to as treatment 1 (Rx-1). Blood only was collected six hours fol-
lowing Rx-1 for blood monocyte isolation, CBC, and serum chemistry profile.
At 12 hours following Rx-1, samples were collected from CBC, serum chemistry
profile, and for isolation of blood monocytes, peritoneal macrophages and
bronchoalveolar macrophages, as described above. The data obtained from
samples collected at six hours is referred to as Phase II data and the data
from the 12 hour samples is referred to as Phase III data.
The last set of samples were collected after the dogs had been admin-
istered prednisone (2 mg/kg BID) orally for seven days. This treatment was
treatment two (Rx-2). Samples were collected approximately 10-12 hours
following the last dose, for CBC, serum chemistry profile and isolation of
blood monocytes, peritoneal macrophages and bronchoalveolar macrophages.
The data obtained was referred to as Phase IV data.
A minimum of 30 days time lapse between procedures was allowed for
recovery from surgery and experimental treatments.
1Dexamethasone sodium phosphate: Invenex Laboratories, Chagrin Falls, OH
kSolu-Delta-Cortef: The Upjohn Co., Kalamazoo, MI 49001
sx etl:
44022
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CHAPTER IV
Results
The data was analyzed statistically by analysis of variance and a
randomized block design. Results were considered to be statistically sig-
nificant if the P value was 1 0.05.
Phagocytosis (Table 1)
The percentage of blood monocytes that were phagocytosis positive was
significantly decreased 12 hours following treatment one (Rx-1). No signif-
icant change was observed following treatment two (Rx-2). There was an
increased percentage of phagocytosis-positive pulmonary alveolar macrophages
at 12 hours following Rx-1, but no change following Rx-2. Peritoneal mac-
rophage phagocytosis was not significantly altered following Rx-1 , but
following Rx-2, the percentage of phagocytosis-positive macrophages was
increased.
Fc-Receptor Activity (Table land 2)
The percentage of blood monocytes with Fc-receptor activity was un-
changed following Rx-1 and increased following Rx-2. The percentage of
pulmonary alveolar macrophages that exhibited Fc-receptor activity increased
12 hours following Rx-1 and was unchanged following Rx-2. Peritoneal mac-
rophage Fc-receptor activity was unchanged following Rx-1 and Rx-2.
There were no significant changes observed in blood, lung or peritoneal
neutrophils in their Fc-receptor activity following either treatment.
Adherence
The adherence of pulmonary alveolar macrophages to plastic cover slips
24
was not changed following the treatments. The adherence of peritoneal mac-
rophages to plastic cover slips was significantly decreased 12 hours follow-
ing Rx-1 and following Rx-2.
Non-Specific Esterase Activity (Table 1 and 3)
The percentage of esterase-positive blood monocytes, pulmonary alveolar
macrophages and peritoneal macrophages increased six and 12 hours following
Rx-1 and following Rx-2.
The percentage of esterase-positive blood lymphocytes increased at six
and 12 hours following Rx-1 and following Rx-2. The percentage of esterase-
positive pulmonary lymphocytes increased following Rx-1 and was unchanged
following Rx-2. The percentage of esterase-positive peritoneal lymphocytes
was unchanged following both treatments.
Differential Counts of Cytospin Preparations (Table 1,2,3 and 4)
Blood monocytes were significantly increased following Rx-1 (six and
12 hours) and Rx-2. Pulmonary macrophages were unchanged following Rx-1 and
were significantly increased following Rx-2. Peritoneal macrophages were
significantly decreased following Rx-1 and were not significantly decreased
following Rx-2.
Blood and lung neutrophils were not significantly changed following
Rx-1 or Rx-2. Peritoneal segmented neutrophils were significantly increased
following Rx-1 and Rx-2.
Blood and peritoneal lymphocytes were decreased following Rx-1 and
Rx-2. Pulmonary lymphocytes were not significantly changed following either
treatment.
25
Blood and peritoneal eosinophils were decreased following Rx-1 (six
and 12 hours) and Rx-2. Pulmonary eosinophils were significantly decreased
after Rx-2.
Complete Blood Counts (Table 5)
All the parameters measured were significantly altered by at least one
treatment with the exception of MCH, MCHC, band neutrophils and fibrinogen.
The total white blood cell counts and absolute neutrophil counts were in-
creased following Rx-1 (six and 12 hours) and Rx-2. Monocytes remained
unchanged following Rx-1 and increased following Rx-2. Eosinophils and
lymphocytes decreased following Rx-1 (six and 12 hours) and Rx-2. The red
blood cell count and hemoglobin concentration decreased 12 hours following
Rx-1 and following Rx-2. The hematocrit remained unchanged except at 12
hours following Rx-1 where it decreased. The plasma total protein increased
after Rx-2.
Serum Chemistries (Table 6)
All parameters were significantly changed by one or more treatments
except glucose and blood urea nitrogen. The SGPT, SAP and total serum
protein were elevated after Rx-2 and were not significantly altered follow-
ing Rx-1 . Six hours following Rx-1 , creatinine and calcium were decreased
and chloride and sodium were increased. Twelve hours following Rx-1,
creatinine, inorganic phosphorus, calcium and potassium were decreased and
chloride was increased. Following Rx-2, the creatinine and chloride were
decreased. Albumin was decreased 12 hours following Rx-1 and increased
following Rx-2.
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CHAPTER V
Discussion
The discussion is divided into two sections with the first section
covering aspects of the mononuclear phagocyte system and its response
following glucocorticoid administration. The goal of the research project
was oriented toward evaluation of the effects glucocorticoids have on
monocyte and macrophages. The second section covers the effect gluco-
corticoids had on hematologic values and on serum chemistries.
_I. Effects of Glucocorticoids on Blood Monocytes, Alveolar Macrophages and
Peritoneal Macrophages
The monocytes and macrophages were evaluated morphologically (percentage
of cells that were non-specific esterase positive), functionally (percentage
of cells demonstrating Fc-receptor activity, percentage of cells phagocy-
tosing heat killed Candida albicans ) and by differential count (a total of
200 cells were counted).
Treatment one (Rx-1) was a 3hock dose of prednisolone sodium succinate
(20 mg/kg) and dexamethasone sodium phosphate (6 mg/kg). Treatment two
(Rx-2) was an immunosuppressive dose of prednisone (2 mg/kg every 12 hours)
administered for seven days.
Specific cytoplasmic glucocorticoid receptors have been identified
in species other than the canine. The presence of specific glucocorticoid
receptors and their interaction with glucocorticoids is considered to be
an important initial step in the cellular mechanism of action of gluco-
corticoids. The presence of specific glucocorticoid receptors in the
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canine species has not been demonstrated, however, it is reasonable to con-
sider that they exist.
Blood Monocytes
The increase in the differential count of blood monocytes following
Rx-1 may have been due to an increased release of bone marrow monocytes
into the circulation and/or a decreased efflux of monocytes leaving the cir-
culation. The percentage of monocytes that were phagocytosis-positive was
decreased 12 hours following Rx-1, which suggests that the population was
.comprised largely of younger cells with less phagocytic ability. This
conclusion would propose the release of bone marrow monocytes ("young
cells") as the reason for an increased differential monocyte count. An
alternative possibility is glucocorticoid inhibition of blood monocyte
phagocytosis. The decrease of blood monocyte phagocytosis following Rx-1
may not be clinically significant, since blood monocytes do not exhibit
a high proportion of phagocytosis, under normal conditions and decreased
phagocytosis by tissue macrophages was not observed.
The increase in the monocyte differential count following Rx-2 was
probably due to increased release of bone marrow-derived monocytes and a
decrease in the number of monocytes leaving the circulation. A steady
state of monocytes entering and leaving the circulation may thus have been
reached at day seven of prednisone therapy, with the population of cells
having a normal distribution at that time. This is supported by the per-
centage of phagocytic cells not being significantly different from the
control group. The percentage of cells with Fc-receptor activity, which
was increased following Rx-2, may have been due either to an increased
number of receptors per cell or an increased affinity of the receptors
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for the Fc portion of the IgG molecule. This observation conflicts with
data from studies in mice and humans where glucocorticoids decrease the
number of Fc-receptors and inhibits the Fc-receptor activity. It would
appear that canine monocytes respond differently than do human monocytes
to glucocorticoids and the dog may therefore not be a good experimental
animal for use in comparisons of glucocorticoid effects on human monocytes.
The decrease in phagocytosis-positive monocytes following Rx-1 and
the increased monocyte Fc-receptor activity following Rx-2 may have been
due to the different drugs used. Dexamethasone may affect phagocytosis
and not Fc-receptors and "long-term" prednisone may not alter phagocytosis
but rather alter Fc-receptor function in blood monocytes.
Alveolar Macrophages
The differential count of the alveolar macrophages did not change
following the shock dose of glucocorticoids. The percentage of phagocy-
tosis-positive and Fc-receptor positive alveolar macrophages increased
following Rx-1 . The alveolar macrophage population may have been
stable due to decreased influx and efflux and the resident alveolar
macrophages may have been altered in their functional capacity by the single
dose of dexamethasone and prednisolone. Glucocorticoid inhibition of the
presence of pulmonary alveolar macrophage plasma membrane associated la
antigen may result in an increase in the population of la antigen negative
macrophages, which have an increase in the number of Fc-receptors per cell.
This is a possible mechanism for the increase in Fc-receptor activity.
Another possible mechanism is that the pulmonary alveolar macrophages are
altered in such a way that they secrete an increased amount of interferon.
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Glucocorticoids and interferon, when incubated in vitro with macrophages,
increase Fc-receptor mediated phagocytosis. Phagocytosis and Fc-receptor
activity was unaltered following Rx-2 and this suggests that the increased
number of alveolar macrophages following Rx-2 may have been due to an increased
influx of functionally unaltered blood monocytes. The difference in the
percentages of phagocytosis and Fc-receptor positive alveolar macrophages
between treatments may have been due to the different glucocorticoid
preparation used.
Peritoneal Macrophages
The decrease in the differential count for peritoneal macrophages
following Rx-1 may have been due to a decrease in monocytes entering the
peritoneal cavity, with the normal number leaving or dying. The differ-
ential count of peritoneal neutrophils was increased following Rx-1 , there-
fore an increase in the total number of peritoneal neutrophils may have
contributed to the decreased percentage of peritoneal monocytes following
Rx-1. The normal differential count for peritoneal macrophages following
Rx-2 may have been due to: 1) prednisone may not alter the population of
peritoneal macrophages as dexamethasone does, or 2) prednisone may have an
early effect on the differential count of the peritoneal cells and over
time, the distribution of cells returns to normal. The increased percentage
of phagocytosis-positive peritoneal macrophages following Rx-2 supports a
decreased efflux of macrophages as a reason for a normal macrophage differ-
ential count, because more mature cells have an increased phagocytic ability.
Fc-receptor function was not altered after Rx-2 which again may be due to
dissociation of function, i.e. the glucocorticoids inhibited the Fc-receptor
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activity but not phagocytic ability. The decreased adherence of the peri-
toneal macrophages may have been the result of glucocorticoid-induced
membrane changes.
Non-specific Esterase Activity
The increase in percentage of non-specific esterase-positive monocytes
and macrophages (alveolar, peritoneal) following both treatments may have
been due to glucocorticoid induction of the esterase enzyme or other alter-
ations affecting enzymatic function.
Summary
The shock dose of glucocorticoids enhanced the phagocytic and Fc-recep-
tor activity of alveolar macrophages and decreased blood monocyte phagocytic
activity, while having no effect on the peritoneal macrophages in their
phagocytic or Fc-receptor activities. The treatment of prednisone (7 days)
enhanced blood monocyte Fc-receptor activity and peritoneal macrophage
phagocytic activity while not altering either Fc-receptor or phagocytic
activity of alveolar macrophages.
Alveolar and peritoneal macrophages and blood monocytes differ in their
response to glucocorticoids. Alveolar macrophages have enhanced Fc-receptor
and phagocytic activity following a shock dose of glucocorticoids, while
peritoneal macrophage phagocytic activity is enhanced following seven days
of prednisone. Blood monocyte response differed between treatments, the
shock dose decreased phagocytic activity, while the prednisone (7 days)
increased Fc-receptor activity. The differential counts varied between
treatments also. Blood monocytes increased in percentage with both treat-
ments while the percentage of alveolar macrophages only increased following
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the prednisone (7 days) and the percentage of peritoneal macrophages de-
creased with the shock dose.
II . Effects of Glucocorticoids on Hematologic Values and on Serum Chemis-
tries
Hematologic Values
A well known classic hematologic response to glucocorticoids in the
canine species is neutrophilia, monocytosis, lymphopenia and eosinopenia.
All were observed following one or both of the treatments. The observed
peripheral neutrophilia and monocytosis is most likely due to an increased
number of cells entering the circulation from the bone marrow and a decreased
number leaving the circulation. Lymphopenia is due to a redistribution of
cells out of the circulation following Rx-1 and probably due to redistribu-
tion and lympholysis following Rx-2. Eosinopenia is due to a decrease in
cells entering from the bone marrow and a redistribution of peripheral cells.
The observed decrease in RBC count, hemoglobin concentration and hema-
tocrit may be the result of redistribution of the red cell mass within the
circulation and/or secondary effects from 3odium retention due to the
mineralocorticoid properties of prednisone and prednisolone. The slight
increase in mean corpuscular volume may be due to older, smaller cells
being redistributed or removed with younger cells remaining, or more young
cells in the circulation. There were statistically significant alterations
in these blood cell parameters, however, the values were all within the
normal ranges. These changes would be most significant in evaluating
clinical cases of anemia where glucocorticoids have been administered.
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Serum Chemistries
The increased serum alkaline phosphatase (SAP) and serum alanine
aminotransferase (ALT) (formerly known as serum glutamic pyruvic trans-
aminase; SGPT) are consistent with previous reports. The increase in SAP
is due to the induction of the steroid-inducible alkaline phosphatase iso-
enzyme. There may also be an increase in hepatic alkaline phosphatase
isoenzyme secondary to glucocorticoid-induced hepatic injury. The elevated
SALT is due partially to enzyme induction and probably partially due to
altered membrane permeability secondary to glucocorticoid administration.
The hepatic enzymes were not significantly elevated six or 12 hours following
glucocorticoid administration, which is useful information for the clinical
setting. This would help in evaluating chemistry results following gluco-
corticoid administration and the recommendation could be made to collect
blood within 12 hours of therapy to avoid drug induced alterations in the
hepatic enzymes.
The decrease in creatinine is probably due to an increase in renal
clearance secondary to the effects of glucocorticoids on urine production.
The decreased inorganic phosphorus at 12 hours following Rx-1 was
probably due to a translocation from extracellular to intracellular loci
and/or an increase in phosphaturia. Infusion of glucose and administration
of insulin result in translocation of inorganic phosphorus into cells.
Following the shock dose of glucocorticoids there was a mild increase in
glucose at six hours that was not statistically significant; however, a
mild increase in glucose may have stimulated insulin production and the
combination of these two may have resulted in a lowering of the serum
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inorganic phosphorus. The mild decrease in serum calcium may have stimulated
parathyroid hormone production, with a result of increased phosphorus ex-
cretion in the urine. The serum phosphorus values were within normal limits
for the laboratory even though statistically significant changes were ob-
served.
Glucocorticoids affect serum calcium by decreasing intestinal calcium
absorption, enhancing renal excretion of calcium and decreasing mineral-
ization of bone. Of these mechanisms, the one most likely to have resulted
in the decreased calcium following the shock dose of glucocorticoids is
the enhanced renal excretion. The other mechanisms would be of more impor-
tance in long-term therapy.
The increased sodium and chloride following Rx-1 was most likely due
to increased sodium (and chloride) retention due to the mineralocorticoid
effect of the prednisolone.
Glucocorticoids increase the release of potassium from muscle and other
cellular stores which in turn result in increased renal potassium excretion
Insulin increases potassium movement from the extracellular to the intra-
cellular spaces. The mineralocorticoid effect of the prednisone may have
resulted in increased potassium excretion. These mechanisms may have
played a role in the observed potassium decrease 12 hours following Rx-1.
The decreased albumin 12 hours following the shock dose may have been
due to a dilutional effect secondary to fluid retention from the mineralo-
corticoid activity of prednisolone. Following seven days of prednisone
therapy, the albumin and total protein were elevated most likely due to
increased hepatic synthesis of globulins and albumin.
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CHAPTER VI
Conclusions
1 . Glucocorticoids alter alveolar and peritoneal macrophage and blood
monocyte function (Fc-receptor activity and phagocytosis of heat
killed Candida albicans ).
a. A single shock dose of prednisolone sodium succinate and dexa-
methasone sodium phosphate altered blood monocyte and alveolar
macrophage function.
b. An immunosuppressive dose of prednisone administered for seven
days altered blood monocyte and peritoneal macrophage function.
2
.
Alveolar and peritoneal macrophages and blood monocytes differ in their
response to glucocorticoids.
a. Twelve hours following the shock dose of glucocorticoids, the
percentage of phagocytosis-positive blood monocytes decreased and
the alveolar macrophages showed increases in the percentage of
phagocytosis-positive cells and Fc-receptor activity.
b. Following the immunosuppressive treatment, the Fc-receptor activity
of the blood monocytes increased and the percentage of phagocytosis-
positive peritoneal macrophages increased.
3. The single shock dose of glucocorticoids and the seven day treatment of
an immunosuppressive dose of glucocorticoid differed in their effect on
alveolar and peritoneal macrophages and blood monocytes.
a. The phagocytic activity of the blood monocytes was altered following
the shock dose, whereas the Fc-receptor activity was altered follow-
ing the immunosuppressive treatment.
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b. The Fc-receptor and phagocytic activity of the alveolar macrophages
was increased following the shock dose, but were unaltered
following the immunosuppressive doses of glucocorticoids.
c. The peritoneal macrophages were not altered in their phagocytic or
Fc-receptor activity following the shock treatment and only the
phagocytic ability was altered following the immunosuppressive
dose.
4
.
The observed changes in Fc-receptor activity and phagocytosing of heat
killed Candida albicans occurred independently of each other.
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ABSTRACT
The objectives of this study were to collect and partially characterize
blood monocytes, bronchoalveolar macrophages and peritoneal macrophages in
the canine prior to glucocorticoid administration, again following a shock
dose of prednisolone sodium succinate/dexamethasone sodium phosphate, and
again following seven days of an immunosuppressive dose of prednisone.
Twelve clinically healthy, mixed breed, adult dogs were used in the study.
Functional assays included 1) evaluation of the percentage of cells that
phagocytosed heat-killed Candida albicans and 2) the percentage of cells
that had Fc-receptor activity for IgG . Morphologic evaluation included
differential counts and a non-specific esterase stain.
Statistically significant results for each treatment included3 :
1) Shock Dose
a. Blood Monocytes
- percent phagocytosis positive decreased at 12 hours
- percent esterase positive increased at 6 and 12 hours
- differential count: increased percentage at 6 and 12 hours
b. Alveolar Macrophages
- percent phagocytosis positive increased at 12 hours
- percent Fc-receptor activity increased at 12 hours
- percent esterase positive increased at 12 hours
aShock dose: Intravenous injection of 20 mg/kg prednisolone sodium
succinate and 6 mg/kg dexamethasone sodium phosphate.
Prednisone (7 days): 2 mg/kg orally every 12 hours
P < 0.05
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c. Peritoneal Macrophages
- percent esterase positive increased at 12 hours
- differential count: decreased percentage at 12 hours
2. Prednisone (seven days)
a. Blood Monocytes
- percent Fc-receptor activity increased
- percent esterase positive increased
- differential count: increased percentage
b. Alveolar Macrophages
- percent esterase positive increased
- differential count: increased percentage
c. Peritoneal Macrophages
- percent phagocytosis positive increased
- percent esterase positive increased
The shock dose of glucocorticoids enhanced the phagocytic and Fc-
receptor activity of alveolar macrophages and decreased blood monocyte
phagocytic activity, while having no effect on the peritoneal macrophages
in their phagocytic or Fc-receptor activities. The treatment of predni-
sone (7 days) enhanced blood monocyte Fc-receptor activity and peritoneal
macrophage phagocytic activity while not altering either Fc-receptor or
phagocytic activity of alveolar macrophages.
Alveolar and peritoneal macrophages and blood monocytes differ in
their response to glucocorticoids. Alveolar macrophages have enhanced
Fc-receptor and phagocytic activity following a shock dose of glucocor-
ticoids, while peritoneal macrophage phagocytic activity is enhanced
following seven days of prednisone. Blood monocyte response differed
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between treatments, the shock dose decreased phagocytic activity, while
the prednisone (7 days) increased Fc-receptor activity. The differential
counts varied between treatments also. Blood monocytes increased in
percentage with both treatments while the percentage of alveolar macro-
phages only increased following the prednisone (7 days) and the percentage
of peritoneal macrophages decreased with the shock dose.
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